David Adler, MD

Neurobehavioral Research Inc.Cedarhurst, New York - 11516 (516-295-7230) |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS2
- SINCE2010

Efficacy Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
May 2010 - July 2011
Depression
Depressive Disorder
Depressive Disorder, Major
Placebo
Agomelatine (Ago178c)



